Works citing this work

2 works

Work: Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products

1. Emerging immune checkpoint targets and combination strategies in blood cancer immunotherapy

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   ArticleCancer Immunotherapy and BiomarkersAnnals of Hematology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.009488

2. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

   E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

   ArticlePluripotent Stem Cells ResearchClinical & Translational Oncology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.018185